Glenn Schattman

Center for Reproductive Medicine and Infertility

Weill Cornell Medical College

BIOGRAPHY

Glenn Schattman has not added Biography.

If you are Glenn Schattman and would like to personalize this page please email our Author Liaison for assistance.

PUBLICATIONS

Breast cancer and fertility preservation.

Placenta Oct, 2008 | Pubmed ID: 18790327

Follicular flushing and in vitro fertilization outcomes in the poorest responders: a randomized controlled trial.

Human reproduction (Oxford, England) Nov, 2013 | Pubmed ID: 24014603

Public reporting of assisted reproductive technology outcomes: past, present, and future.

American journal of obstetrics and gynecology Feb, 2015 | Pubmed ID: 24813599

Comparison of perinatal outcomes following fresh and frozen-thawed blastocyst transfer.

International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics Oct, 2016 | Pubmed ID: 27388034

Ex vivo retrieval and cryopreservation of oocytes from oophorectomized specimens for fertility preservation in a BRCA1 mutation carrier with ovarian cancer.

Fertility and sterility 08, 2017 | Pubmed ID: 28629583

Random-start ovarian stimulation in women desiring elective cryopreservation of oocytes.

Reproductive biomedicine online Oct, 2017 | Pubmed ID: 28647355

Engineered endothelium provides angiogenic and paracrine stimulus to grafted human ovarian tissue.

Scientific reports Aug, 2017 | Pubmed ID: 28811567

Gonadotropin-releasing hormone agonist trigger increases the number of oocytes and embryos available for cryopreservation in cancer patients undergoing ovarian stimulation for fertility preservation.

Fertility and sterility 09, 2017 | Pubmed ID: 28865552

Chromosomal mosaicism in human preimplantation embryos: another fact that cannot be ignored.

Fertility and sterility Jan, 2018 | Pubmed ID: 29307401

INSTITUTIONS

Weill Cornell Medical College

JOVE ARTICLES

Co-transplantation of Human Ovarian Tissue with Engineered Endothelial Cells: A Cell-based Strategy Combining Accelerated Perfusion with Direct Paracrine Delivery

Limor Man¹,

Laura Park¹,

Richard Bodine¹,

Michael Ginsberg²,

Nikica Zaninovic³,

Glenn Schattman¹,

Robert E. Schwartz⁴,

Zev Rosenwaks^1,3,

Daylon James^1,3

¹Center for Reproductive Medicine and Infertility, Weill Cornell Medical College,

², Angiocrine Biosciences, Inc.,

³Tri-Institutional Stem Cell Derivation Laboratory, Weill Cornell Medical College,

⁴Joan and Sanford I. Weill Department of Medicine, Weill Cornell Medical College

Bioengineering

Privacy

Policies

Recommend to library

JoVE NEWSLETTERS

Research

JoVE Journal
Methods Collections
JoVE Encyclopedia of Experiments
Archive

Education

JoVE Core
JoVE Business
JoVE Science Education
JoVE Lab Manual
Faculty Resource Center
Faculty Site

Authors

Overview
Publishing Process
Editorial Board
Scope and Policies
Peer Review
FAQ
Submit

Librarians

Overview
Testimonials
Subscriptions
Access
Resources
Library Advisory Board
FAQ

ABOUT JoVE

Overview
Leadership
Blog
JoVE Help Center

Glenn Schattman

.css-o250i3{font-size:18px;font-family:Open Sans,sans-serif;line-height:21.6px;}Center for Reproductive Medicine and Infertility

Weill Cornell Medical College

Co-transplantation of Human Ovarian Tissue with Engineered Endothelial Cells: A Cell-based Strategy Combining Accelerated Perfusion with Direct Paracrine Delivery

Center for Reproductive Medicine and Infertility